Stockreport

National Institute on Drug Abuse Presents Data on Trevena’s TRV734 at the 57th Annual Meeting of the American College of Neuropsychopharmacology

Trevena, Inc.  (TRVN) 
Last trevena, inc. earnings: 3/12 07:01 am Check Earnings Report
US:NASDAQ Investor Relations: investors.trevena.com/investor-relations
PDF CHESTERBROOK, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new [Read more]